Karla Daniele, MD
Surgical Oncology · Lubbock, TXNPI 1326426354
Payments from drug & device makers
Across 43 payments — averaging $55.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$818
- Endomagnetics Ltd$561
- Leica Microsystems Inc.$212
- KCI USA, Inc.$138
- Acell, Inc.$122
- Smith+Nephew$119
- plus $399 from 10 others
What the payments were for
- Consulting fees$191%
- Travel & lodging$100%
- Food & beverage$2,33999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $818 |
| Endomagnetics Ltd | 5 | $561 |
| Leica Microsystems Inc. | 2 | $212 |
| KCI USA, Inc. | 2 | $138 |
| Acell, Inc. | 2 | $122 |
| Smith+Nephew | 1 | $119 |
| Motiva USA, LLC | 1 | $98 |
| Mallinckrodt Enterprises LLC | 5 | $84 |
| Axogen | 1 | $80 |
| Histosonics, Inc. | 1 | $28 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Avita Medical Americas, LLC | 1 | $19 |
| Z-medica, LLC | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| Kls-martin L.p. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Magseed$551
- Magtrace$551
- NATRELLE SALINE-FILLED BREAST IMPLANTS$298
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$181
- NEOPROBE$169
- ABTHERA$125
- PICO 7$119
- Humira$107
How this compares
$2,368 in reported general payments places this provider in the 55th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 19 | $32 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Lubbock
- Tyler MouwLubbock$5K
- Jennifer WargoHouston$6M
- Ernest CampHouston$3.6M
- Hop Tran CaoHouston$928K
- Elizabeth GrubbsHouston$750K
- Alastair ThompsonHouston$568K
- Merrick RossHouston$283K
- Adam YoppDallas$281K
- Allison DipasqualeDallas$272K
- Patricio PolancoDallas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.